Literature DB >> 9676575

Ligand recognition by the I domain-containing integrins.

S K Dickeson1, S A Santoro.   

Abstract

Seven of the integrin alpha subunits described to date, alpha 1, alpha 2, alpha L, alpha X, alpha d, alpha M and alpha E, contain a highly conserved I (or A) domain of approximately 200 amino acid residues inserted near the amino-terminus of the subunit. As the result of a variety of independent experimental approaches, a large body of data has recently accumulated that indicates that the I domains are independent, autonomously folding domains capable of directly binding ligands that play a necessary and important role in ligand binding by the intact integrins. Recent crystallographic studies have elucidated the structures of recombinant alpha M and alpha L I domains and also delineated a novel divalent cation-binding motif within the I domains (metal ion-dependent adhesion site, MIDAS) that appears to mediate the divalent cation binding of the I domains and the I domain-containing integrins to their ligands.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9676575     DOI: 10.1007/s000180050184

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  24 in total

Review 1.  Alpha E beta 7.

Authors:  P J Kilshaw
Journal:  Mol Pathol       Date:  1999-08

2.  Effects of I domain deletion on the function of the beta2 integrin lymphocyte function-associated antigen-1.

Authors:  B Leitinger; N Hogg
Journal:  Mol Biol Cell       Date:  2000-02       Impact factor: 4.138

3.  Stabilizing the integrin alpha M inserted domain in alternative conformations with a range of engineered disulfide bonds.

Authors:  Motomu Shimaoka; Chafen Lu; Azucena Salas; Tsan Xiao; Junichi Takagi; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-04       Impact factor: 11.205

4.  Binding of a fibrinogen mimetic stabilizes integrin alphaIIbbeta3's open conformation.

Authors:  R R Hantgan; M Rocco; C Nagaswami; J W Weisel
Journal:  Protein Sci       Date:  2001-08       Impact factor: 6.725

5.  Mannheimia haemolytica leukotoxin activates a nonreceptor tyrosine kinase signaling cascade in bovine leukocytes, which induces biological effects.

Authors:  S Jeyaseelan; M S Kannan; R E Briggs; P Thumbikat; S K Maheswaran
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

6.  Prognostic values of tumor endothelial markers in patients with colorectal cancer.

Authors:  K A Rmali; M C A Puntis; W G Jiang
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

7.  A novel COCH mutation associated with autosomal dominant nonsyndromic hearing loss disrupts the structural stability of the vWFA2 domain.

Authors:  Hyun-Ju Cho; Hong-Joon Park; Maria Trexler; Hanka Venselaar; Kyu Yup Lee; Nahid G Robertson; Jeong-In Baek; Beom Sik Kang; Cynthia C Morton; Gert Vriend; László Patthy; Un-Kyung Kim
Journal:  J Mol Med (Berl)       Date:  2012-05-19       Impact factor: 4.599

8.  Identification of inhibitors of α2β1 integrin, members of C-lectin type proteins, in Echis sochureki venom.

Authors:  Piotr Jakubowski; Juan J Calvete; Johannes A Eble; Philip Lazarovici; Cezary Marcinkiewicz
Journal:  Toxicol Appl Pharmacol       Date:  2013-03-13       Impact factor: 4.219

9.  Multiple epiphyseal dysplasia mutations in MATN3 cause misfolding of the A-domain and prevent secretion of mutant matrilin-3.

Authors:  Sally L Cotterill; Gail C Jackson; Matthew P Leighton; Raimund Wagener; Outi Mäkitie; William G Cole; Michael D Briggs
Journal:  Hum Mutat       Date:  2005-12       Impact factor: 4.878

Review 10.  Cell targeting by the Staphylococcus aureus pore-forming toxins: it's not just about lipids.

Authors:  Ashley L DuMont; Victor J Torres
Journal:  Trends Microbiol       Date:  2013-11-11       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.